Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease

Kidney International

Volumn 52, Issue 3, 1997, Pages 607-613

  Baboolal, Keshwar ^a   Ravine, David ^b   Daniels, Joe ^b   Williams, Nigel ^b   Holmans, Peter ^b   Coles, Gerald A ^b   Williams, John D ^b  

^a Cardiff Royal Infirmary   (United Kingdom)

^b NONE

Author keywords

ACE gene deletion polymorphism; Adult polycystic kidney disease; Renal failure

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL PROTOCOL; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL;

EID: 0030759022     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.373     Document Type: Article

References (50)

1. BENNETT WM: Clinical features of autosomal dominant polycystic kidney disease. Kidney Int 42(Suppl 42):S74-S79, 1993
2. CHOUKROUN G, ITAKURA Y, ALBOUZE G, CHRISTOPHE JL, MAN NK, GRUNFELD JP, JUNGERS P: Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 6:1634-1642, 1995
3. MILUTINOVIC J, FIALKOW PJ, AGODOA LY, PHILIPS LA, RUDD TG, BRYANT JI: Autosomal polycystic kidney disease: Symptoms and clinical findings. Q J Med 212:511-522, 1984
4. CHURCHILL DN, BEAR JC, MORGAN J, PAYNE RH, MCMANAMON PJ, GAULT MH: Prognosis of adult polycystic kidney disease re-evaluated. Kidney Int 26:190-193, 1984
5. DALGAARD OZ: Bilateral polycystic disease of the kidneys. A follow up of 284 patients and their families. Acta Med Scand 328:1-233, 1957
6. EUROPEAN PKD CONSORTIUM: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77:6-20, 1994
7. REEDERS ST, BREUNING MH, DAVIES KE, WEATHERALL DJ: A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317:542-544, 1985
8. PETERS DJM, SPRUIT L, SANDKIJL LA, SARIS JJ: Localisation of the second gene for autosomal dominant polycystic kidney disease on chromosome 4. Nature Genet 5:359-362, 1993
9. DAOUST MC, BICHET DG, SOMLO S: A French Canadian family with autosomal dominant polycystic kidney disease unlinked to ADPKD1 and ADPKD 2. (abstract) J Am Soc Nephrol 14:262, 1993
10. DE ALMEIDA S, DE ALMEIDA E: ADPKD: A large Portugese family not linked either to chromosome 16 or chromosome 4. (abstract) Third International Workshop on Polycystic Kidney Disease, Leiden, Oct 1994
11. RAVINE D, WALKER R, GIBSON RN, FORREST SM, RICHARDS RI, FRIEND K, SHEFFIELD LJ, KINCAID-SMITH P, DANKS DM: Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet 340:1330-1333, 1992
12. TORRA R, BADENAS C, DARNELL A, NICOLAU C, VOLPINI V, REVERT L, ESTIVILLI X: Linkage, clinical features and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol 7:2142-2151, 1996
13. PARFREY PS, BEAR JC, MORGAN J, CRAMER BC, MCMANAMON PJ, GAULT M, CHURCHILL DN, SINGH M, HEWITT R, SOMLO S, REEDERS ST: The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 323:1085-1090, 1990
14. GRAHAM PC, LINDOP GBM: The anatomy of the renin secreting cell in adult polycystic kidney disease. Kidney Int 33:1084-1090, 1988
15. CHAPMAN AB, JOHNSON A, GABOW PA, SCHRIER RW: The renin angiotensin system and autosomal polycystic kidney disease. N Engl J Med 323:1091-1096, 1990
16. GABOW PA, JOHNSON AM, KAEHENY WD: Factors affecting the progression of renal disease in autosomal dominant polycystic kidney disease. Kidney Int 41:1311-1319, 1992
17. IGLESIAS CG, TORRES VE, OFFORD KP, BEARD CM, KURLAND LT: Epidemiology of adult polycystic kidney disease. Olmsted County, Minnesota: 1935-1980. Am J Kid Dis 2:630-639, 1983
18. TORRES VE, DONOVAN KA, SCICLI G, HOLLEY KE, THIBODEAU SN, CARRETERO OA, INAGAMI T, MCATEER JA, JOHNSON CM: Synthesis of renin by tubulocystic epithelium in autosomal dominant polycystic kidney disease. Kidney Int 42:364-373, 1992
19. WATSON ML, MACNICOL AM, ALLAN PL, WRIGHT AF: Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. Kidney Int 41:206-210, 1992
20. JEUNMATTRE X, SOUBRIER F, KOTELEVTSEV YV, LIFTONRP, WILLIAMS CS, CHARRU A, HUNT SC, HOPKINS PN, WILLIAMS RR, LALOUELL JM, CORVOL P: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
21. MARRE M, BERNADET MP, GALLOIS Y, SAVENGER F, GUYENE TT, HALLAB M, CAMBIEN F, PASSA P, ALHENAC-GELAS F: Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
22. DUDLEY CRK, KEAVENEY B, STRATTON IM, TURNER RC, RATCLIFFE PJ: UK. prospective diabetes study XV. Relationship of renin angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48:1907-1912, 1995
23. YOSHIDA H, KURIYAMA S, ATSUMI Y, TOMONARI H, MITARAI T, HAMAGUCHI A, KUBO H, KAWAGUCHI Y, KON V, MATSUOKA T, ICHIKAWA I, SAKAI O: Angiotensin 1 converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50:657-664, 1995
24. YOSHIDA H, MITARAI T, KAWAMURA T, KITAJIMA T, KANAI T, MIYAZKI Y, KAWAGUCHI Y, KUBO H, NAGASAWA R, ICHIKAWA I, SAKAI O: Role of deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169, 1995
25. HARDEN PN, GEDDES C, ROWE PA, MCILROY JH, BOULTON-JONES M, RODGER S, JUNOR BJR, BRIGGS JD, CONNELL JMC, JARDINE AG: Polymorphisms in the angiotensin converting enzyme gene and progression of IgA nephropathy. Lancet 345:1540-1542, 1995
26. HUNLEY TA, JULIAN BA, PHILIPS JA, SUMMAR ML, YOSHIDA H, HORN, BROWN NJ, FOGO A, ICHIKAWA I, KON V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-578, 1996
27. PARVING HH, JACOBSEN P, TARNOW, L, ROSSING P, LECERF L, POIRIER O, CAMBIEN F: Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: Observational follow up study. Brit Med J 313:591-594, 1996
28. TIRET L, BONNARDEAUX A, POIRIER O, RICARD S, MARQUES-VIDAL P, EVANS A, ARVEILAER D, LUC G, KEE F, DUCIMETIERE P, SOUBRIER F, CAMBIEN F: Synergistic effects of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphism on risk of myocardial infarction. Lancet 344:910-913, 1994
29. BONNARDEAUX A, DAVIES E, JEUNMAITRE X, FERY I, CHARRU A, CLAUSER E, TIRET L, CAMBIEN F, CORVOL P, SOUBRIER F: Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension 24:63-69, 1994
30. FOGARTY DG, HARRON JC, HUGHES AE, NEVIN NC, DOHERTY CC, MAXWELL AP: A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 45:1204-1210, 1996
31. RIGAT B, HUBERT C, ALHENAC GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance in serum enzyme levels. J Clin Invest 86:1343-1346, 1990
32. COSTEROUSSE O, ALLEGRINI J, LOPEZ M, ALHENAC GELAS F: Angiotensin I converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T lymphocytes. Biochem J 290:33-40, 1993
33. ALLAN DR, MCKNIGHT JA, KIFOR I, COLETTI CM, HOLLENBERG NK: Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24:516-522, 1994
34. ROBERTS J: National Center for Health Statistics. Blood pressure levels of persons 6-74 years: United States 1971-74. Vital and Health Statistics (Series 11, No 203), Washington DC, Government Printing Office, 1977
35. SHANMUGAM V, SELL KW, SAHA BK: Mistyping ACE heterozygotes. PCR Methods and Applications 3:120-121, 1993
36. RALL JE, ODEL HM: Congenital Polycystic disease of the kidney: Review of the literature, and data on 207 cases. Am J Med Sci 218:399-407, 1949
37. SIMON HB, THOMPSON GJ: Congenital renal polycystic kidney disease. JAMA 159:657-662, 1955
38. PERAL B, GAMBLE V, ONG ACM, JOSE L, MILLAN S, HARRIS PC: Mutation detection in polycystic kidney disease (PKD1) gene. (abstract) J Am Soc Nephrol 7:1620, 1996
39. VAN ESSEN GG, RENSMA PL, DE ZEEUW D, SLUITER WJ, SCHEFFER H, APPERLOO AJ, DE JONG PE: Association between angiotensin converting enzyme gene polymorphism and failure of renoprotective therapy. Lancet 347:114-115, 1996
40. SCHMIDT S, SCHONE N, RITZ E: Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Group. Kidney Int 47:1176-1181, 1995
41. TARNOW L, CAMBIEN F, ROSSING P, NIELSON FS, HANSEN BV, LECERT L, POIRIER O, DANILOV S, PARVING HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM. Diabetes 44(5):489-494 1995
42. GEBETH S, STIER E, ZEIER M, MAYER G, RAMBAUSEK M, RITZ E: More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension. J Am Soc Nephrol 6:1643-1648, 1995
43. DAVIES F, COLES GA, HARPER PS, WILLIAMS AJ, EVANS C, COCHLIN D: Polycystic kidney disease re-evaluated: A population based study. Q J Med 290:477-485, 1991
44. NOMURA H, KONI I, MICHISHITA Y, MORISE T, TAKEDA R: Angiotensin converting enzyme gene polymorphism in haemodialysis patients. Lancet 343:482-483, 1994
45. RUIZ J, BLANCHE H, COHEN N, VELHO G, CAMBIEN F, COHEN D, PASSA P, FROGUEL P: Insertion/deletion polymorphism of the angiotensin converting enzyme gene is strongly associated with coronary heart disease in non insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 91:3662-3665, 1994
46. UEDA S, ELLIOTT HL, MORTON JJ, CONNELL JMC: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin converting enzyme. Hypertension 25:1266-1269, 1995
47. HARRAP SB, DAVIES DL, MACNICOL AM, DOMINICZAK AF, FRASER R, WRIGHT AF, WATSON ML, BRIGGS JD: Renal, cardiovascular and hormonal characterisitics of young adults with autosomal dominant polycystic kidney disease. Kidney Int 40:501-508, 1991
48. MORIYAMA T, KITAMURA H, OCHI S, IZUMI M, YOKOYAMA K, YAMAUCHI A, UEDA N, KAMADA T, IMAI E: Association of angiotensin I converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 6:1674-1678, 1995
49. TIRET L, RIGAT B, VISVIKIS S, BREDA C, CORVOL P, CAMBIEN F, SOUBRIER F: Evidence from combined segregation and linkage analysis, that a variant of the angiotensin 1 converting enzyme (ACE) gene controls plasma ACE levels. Am J Human Genet 51:187-205, 1992
50. MCKENZIE CA, JULIER C, FORRESTER T, MCFARLANE-ANDERSON N, KEAVENEY B, LATHROP GM, RATCLIFFE P, FARRALL M: Segregation and linkage analysis of serum angiotensin 1 converting enzyme levels: Evidence of two quantitative-trait loci. Am J Human Genet 57:1426-1435, 1995